Share on LinkedInShare on LinkedIn

ARTICLE · 18 OCTOBER 2019

USPTO To Tweak PTA Rules In View Of Supernus

In Supernus Pharmaceuticals, Inc. v. Iancu, the Federal Circuit held that the USPTO cannot charge a Patent Term Adjustment (PTA) deduction for "applicant delay"

United StatesIntellectual Property

In Supernus Pharmaceuticals, Inc. v. Iancu, the Federal Circuit held that the USPTO cannot charge a Patent Term Adjustment (PTA) deduction for “applicant delay” during a period when the applicant “could have done nothing to advance prosecution.” The PTA deduction at issue was charged under 37 CFR § 1.703(c)(8) for an Information Disclosure Statement (IDS) filed after a Request for Continued Examination (RCE) had been filed, but the USPTO proposes to make changes to other PTA rules to comply with the court’s interpretation of  35 USC § 154(b)(2)(C).

Proposed Tweaks to PTA Rules

In the Federal Register Notice dated October 4, 2019, the USPTO interprets Supernus as holding “that a reduction of patent term adjustment under 35 U.S.C. 154(b)(2)(C) must be equal to the period of time during which the applicant failed to engage in reasonable efforts to conclude prosecution of the application.” The USPTO admits that “[s]everal provisions in 37 CFR 1.704 specify a period of

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from